calcium chloride (Rx)

Brand and Other Names:CaCl or CaCl(2)
  • Print

Dosing & Uses

AdultPediatric

Dosage Forms & Strengths

injectable solution

  • 100mg/mL

Hypocalcemia, Emergency Treatment

500-1000 mg IV over 5-10 minutes; may repeat as necessary

Arrhythmias, Emergent

Indicated for arrhythmias associated with hypocalcemia, hyperkalemia, or hypermagnesemia

500-1000 mg IV over 5-10 minutes

Hypermagnesemia

500-1000 mg IV over 2-5 minutes; observe the patient for signs of recovery; may repeat if CNS depression persists

Calcium Channel Blocker Overdose

1-2 g IV infused over 10-20 min; may repeat every 20 minutes prn up to 5 doses

Beta-blocker Overdose, Refractory to Glucagon & High Dose Vasopressor

1000 mg IV bolus via central line

Other Information

1 g (10 mL) vials of calcium chloride 10% solution contain 273 mg (13.6 mEq) elemental calcium

Dosage Forms & Strengths

injectable solution

  • 100 mg/mL

Hypocalcemia, Emergency Treatment

Infants: <75 mg (20 mg elemental Ca) IV; may repeat as necessary

Children: 75-519 mg (20-140 mg elemental Ca) IV, may repeat as necessary

Hypocalcemic Tetany

Neonates: 171 mg/kg/day IV in divided doses  

Infants and Children: 10 mg/kg IV over 5-10 min TID/QID; alternatively, may administer 35-50 mg/kg IV TID/QID

Other Information

(Not recommended) Cardiac Arrest: 20 mg/kg IV push every 10 minutes as necessary

Other Indications & Uses

Medullary thyroid cancer diagnosis

Next:

Interactions

Interaction Checker

and calcium chloride

No Results

     activity indicator 
    No Interactions Found
    Interactions Found

    Contraindicated

      Serious - Use Alternative

        Significant - Monitor Closely

          Minor

            All Interactions Sort By:
             activity indicator 

            Contraindicated (1)

            • ceftriaxone

              ceftriaxone, calcium chloride. Other (see comment). Contraindicated. Comment: Contraindicated in neonates if they require (or are expected to require) treatment with calcium containing IV solutions, including continuous calcium containing infusions such as parenteral nutrition because of the risk of precipitation of ceftriaxone and calcium. Separate IV ceftriaxone and IV calcium by at least 48 hrs. However, in patients other than neonates, ceftriaxone and calcium containing solutions may be administered sequentially of one another if the IV infusion lines are thoroughly flushed between infusions with a compatible fluid.

            Serious - Use Alternative (7)

            • baloxavir marboxil

              calcium chloride will decrease the level or effect of baloxavir marboxil by cation binding in GI tract. Avoid or Use Alternate Drug. Baloxavir may bind to polyvalent cations resulting in decreased absorption. Studies in monkeys showed concurrent use with calcium, aluminum, or iron caused significantly decreased plasma levels. Human studies not conducted.

            • demeclocycline

              calcium chloride, demeclocycline. Either decreases levels of the other by inhibition of GI absorption. Applies only to oral form of both agents. Avoid or Use Alternate Drug. Separate by 2 hours.

            • doxycycline

              calcium chloride, doxycycline. Either decreases levels of the other by inhibition of GI absorption. Applies only to oral form of both agents. Avoid or Use Alternate Drug. Separate by 2 hours.

            • eltrombopag

              calcium chloride decreases levels of eltrombopag by inhibition of GI absorption. Applies only to oral form of both agents. Contraindicated. Separate by at least 4 hours.

            • minocycline

              calcium chloride, minocycline. Either decreases levels of the other by inhibition of GI absorption. Applies only to oral form of both agents. Avoid or Use Alternate Drug. Separate by 2 hours.

            • oxytetracycline

              calcium chloride, oxytetracycline. Either decreases levels of the other by inhibition of GI absorption. Applies only to oral form of both agents. Avoid or Use Alternate Drug. Separate by 2 hours.

            • tetracycline

              calcium chloride, tetracycline. Either decreases levels of the other by inhibition of GI absorption. Applies only to oral form of both agents. Avoid or Use Alternate Drug. Separate by 2 hours.

            Monitor Closely (51)

            • acebutolol

              calcium chloride decreases effects of acebutolol by unspecified interaction mechanism. Use Caution/Monitor.

            • alendronate

              calcium chloride decreases levels of alendronate by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor. Separate by 30 minutes.

            • amlodipine

              calcium chloride decreases effects of amlodipine by pharmacodynamic antagonism. Use Caution/Monitor.

            • atenolol

              calcium chloride decreases effects of atenolol by unspecified interaction mechanism. Use Caution/Monitor.

            • betaxolol

              calcium chloride decreases effects of betaxolol by unspecified interaction mechanism. Use Caution/Monitor.

            • bisoprolol

              calcium chloride decreases effects of bisoprolol by unspecified interaction mechanism. Use Caution/Monitor.

            • carvedilol

              calcium chloride decreases effects of carvedilol by unspecified interaction mechanism. Use Caution/Monitor.

            • celiprolol

              calcium chloride decreases effects of celiprolol by unspecified interaction mechanism. Use Caution/Monitor.

            • ciprofloxacin

              calcium chloride decreases effects of ciprofloxacin by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor. Ciprofloxacin should be administered 2 hr before or 6 hr after calcium salts.

            • clevidipine

              calcium chloride decreases effects of clevidipine by pharmacodynamic antagonism. Use Caution/Monitor.

            • deferiprone

              calcium chloride decreases levels of deferiprone by enhancing GI absorption. Applies only to oral form of both agents. Modify Therapy/Monitor Closely. Deferiprone may bind polyvalent cations (eg, iron, aluminum, and zinc), separate administration by at least 4 hr between deferiprone and other medications (eg, antacids), or supplements containing these polyvalent cations.

            • delafloxacin

              calcium chloride will decrease the level or effect of delafloxacin by cation binding in GI tract. Modify Therapy/Monitor Closely. Oral delafloxacin form chelates with alkaline earth and transition metal cations. Administer oral delafloxacin at least 2 hr before or 6 hr after these agents.

            • digoxin

              calcium chloride increases effects of digoxin by pharmacodynamic synergism. Use Caution/Monitor.

            • diltiazem

              calcium chloride decreases effects of diltiazem by pharmacodynamic antagonism. Use Caution/Monitor.

            • esmolol

              calcium chloride decreases effects of esmolol by unspecified interaction mechanism. Use Caution/Monitor.

            • estramustine

              calcium chloride decreases levels of estramustine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor. Patients should take estramustine with water at least 1h before or 2h after meals.

            • etidronate

              calcium chloride decreases levels of etidronate by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor. Separate by 30 minutes.

            • felodipine

              calcium chloride decreases effects of felodipine by pharmacodynamic antagonism. Use Caution/Monitor.

            • fleroxacin

              calcium chloride, fleroxacin. Either decreases levels of the other by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor. Separate by 2 hours.

            • gemifloxacin

              calcium chloride, gemifloxacin. Either decreases levels of the other by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor. Separate by 2 hours.

            • ibandronate

              calcium chloride decreases levels of ibandronate by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor. Separate by 30 minutes.

            • isradipine

              calcium chloride decreases effects of isradipine by pharmacodynamic antagonism. Use Caution/Monitor.

            • labetalol

              calcium chloride decreases effects of labetalol by unspecified interaction mechanism. Use Caution/Monitor.

            • levofloxacin

              calcium chloride, levofloxacin. Either decreases levels of the other by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor. Separate by 2 hours.

            • levothyroxine

              calcium chloride decreases levels of levothyroxine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor. Separate by 2 hours.

            • metoprolol

              calcium chloride decreases effects of metoprolol by unspecified interaction mechanism. Use Caution/Monitor.

            • moxifloxacin

              calcium chloride, moxifloxacin. Either decreases levels of the other by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor. Separate by 2 hours.

            • nadolol

              calcium chloride decreases effects of nadolol by unspecified interaction mechanism. Use Caution/Monitor.

            • nebivolol

              calcium chloride decreases effects of nebivolol by unspecified interaction mechanism. Use Caution/Monitor.

            • nicardipine

              calcium chloride decreases effects of nicardipine by pharmacodynamic antagonism. Use Caution/Monitor.

            • nifedipine

              calcium chloride decreases effects of nifedipine by pharmacodynamic antagonism. Use Caution/Monitor.

            • nisoldipine

              calcium chloride decreases effects of nisoldipine by pharmacodynamic antagonism. Use Caution/Monitor.

            • ofloxacin

              calcium chloride, ofloxacin. Either decreases levels of the other by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor. Separate by 2 hours.

            • omadacycline

              calcium chloride will decrease the level or effect of omadacycline by inhibition of GI absorption. Applies only to oral form of both agents. Modify Therapy/Monitor Closely. Multivalent cation-containing products may impair absorption of tetracyclines, which may decrease its efficacy. Separate dosing of tetracyclines from these products.

            • pamidronate

              calcium chloride decreases levels of pamidronate by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor. Separate by 30 minutes.

            • penbutolol

              calcium chloride decreases effects of penbutolol by unspecified interaction mechanism. Use Caution/Monitor.

            • pindolol

              calcium chloride decreases effects of pindolol by unspecified interaction mechanism. Use Caution/Monitor.

            • propranolol

              calcium chloride decreases effects of propranolol by unspecified interaction mechanism. Use Caution/Monitor.

            • rilpivirine

              calcium chloride decreases levels of rilpivirine by increasing gastric pH. Applies only to oral form of both agents. Modify Therapy/Monitor Closely. Coadministration of antacids with rilpivirine may cause significant decreases in rilpivirine plasma concentrations because of increased gastric pH. If antacids must be administered, they should given at least 2 hr before or at least 4 hr after rilpivirine.

            • risedronate

              calcium chloride decreases levels of risedronate by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor. Separate by 30 minutes.

            • sarecycline

              calcium chloride will decrease the level or effect of sarecycline by inhibition of GI absorption. Applies only to oral form of both agents. Modify Therapy/Monitor Closely. Multivalent cation-containing products may impair absorption of tetracyclines, which may decrease its efficacy. Separate dosing of tetracyclines from these products.

            • sodium sulfate/?magnesium sulfate/potassium chloride

              sodium sulfate/?magnesium sulfate/potassium chloride increases toxicity of calcium chloride by Other (see comment). Use Caution/Monitor. Comment: Coadministration with medications that cause fluid and electrolyte abnormalities may increase the risk of adverse events of seizure, arrhythmias, and renal impairment.

            • sodium sulfate/potassium sulfate/magnesium sulfate

              sodium sulfate/potassium sulfate/magnesium sulfate increases toxicity of calcium chloride by Other (see comment). Use Caution/Monitor. Comment: Coadministration with medications that cause fluid and electrolyte abnormalities may increase the risk of adverse events of seizure, arrhythmias, and renal impairment.

            • sotalol

              calcium chloride decreases effects of sotalol by unspecified interaction mechanism. Use Caution/Monitor.

            • squill

              calcium chloride increases toxicity of squill by unspecified interaction mechanism. Use Caution/Monitor.

            • strontium ranelate

              calcium chloride decreases levels of strontium ranelate by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor. Applies to oral form of calcium. Separate by 2 hr.

            • tiludronate

              calcium chloride decreases levels of tiludronate by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor. Separate by 30 minutes.

            • timolol

              calcium chloride decreases effects of timolol by unspecified interaction mechanism. Use Caution/Monitor.

            • verapamil

              calcium chloride decreases effects of verapamil by pharmacodynamic antagonism. Use Caution/Monitor.

            • vitamin D

              vitamin D, calcium chloride. Other (see comment). Use Caution/Monitor. Comment: The concurrent use of vitamin D with calcium salts is generally beneficial; in some patients this combination may result in hypercalcemia.

            • zoledronic acid

              calcium chloride decreases levels of zoledronic acid by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor. Separate by 30 minutes.

            Minor (50)

            • amikacin

              amikacin decreases levels of calcium chloride by inhibition of GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.

            • amiloride

              amiloride decreases levels of calcium chloride by increasing renal clearance. Minor/Significance Unknown.

            • bendroflumethiazide

              bendroflumethiazide increases levels of calcium chloride by decreasing renal clearance. Minor/Significance Unknown. Risk of alkalosis, hypercalcemia.

            • budesonide

              budesonide decreases levels of calcium chloride by increasing elimination. Minor/Significance Unknown.

            • bumetanide

              bumetanide decreases levels of calcium chloride by increasing renal clearance. Minor/Significance Unknown.

            • caffeine

              caffeine decreases levels of calcium chloride by increasing renal clearance. Minor/Significance Unknown.

            • calcitriol topical

              calcitriol topical increases levels of calcium chloride by pharmacodynamic synergism. Minor/Significance Unknown. Topical calcitriol may lead to hypercalcemia.

            • carbonyl iron

              calcium chloride decreases levels of carbonyl iron by inhibition of GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.

              carbonyl iron increases levels of calcium chloride by enhancing GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.

            • chlorothiazide

              chlorothiazide increases levels of calcium chloride by decreasing renal clearance. Minor/Significance Unknown. Risk of alkalosis, hypercalcemia.

            • chlorthalidone

              chlorthalidone increases levels of calcium chloride by decreasing renal clearance. Minor/Significance Unknown. Risk of alkalosis, hypercalcemia.

            • cortisone

              cortisone decreases levels of calcium chloride by increasing elimination. Minor/Significance Unknown.

            • cyclopenthiazide

              cyclopenthiazide increases levels of calcium chloride by decreasing renal clearance. Minor/Significance Unknown. Risk of alkalosis, hypercalcemia.

            • deflazacort

              deflazacort decreases levels of calcium chloride by increasing elimination. Minor/Significance Unknown.

            • dexamethasone

              dexamethasone decreases levels of calcium chloride by increasing elimination. Minor/Significance Unknown.

            • drospirenone

              drospirenone decreases levels of calcium chloride by increasing renal clearance. Minor/Significance Unknown.

            • ethacrynic acid

              ethacrynic acid decreases levels of calcium chloride by increasing renal clearance. Minor/Significance Unknown.

            • ferric maltol

              ferric maltol increases levels of calcium chloride by enhancing GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.

              calcium chloride decreases levels of ferric maltol by inhibition of GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.

            • ferrous fumarate

              calcium chloride decreases levels of ferrous fumarate by inhibition of GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.

              ferrous fumarate increases levels of calcium chloride by enhancing GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.

            • ferrous gluconate

              ferrous gluconate increases levels of calcium chloride by enhancing GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.

              calcium chloride decreases levels of ferrous gluconate by inhibition of GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.

            • ferrous sulfate

              ferrous sulfate increases levels of calcium chloride by enhancing GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.

            • fludrocortisone

              fludrocortisone decreases levels of calcium chloride by increasing elimination. Minor/Significance Unknown.

            • furosemide

              furosemide decreases levels of calcium chloride by increasing renal clearance. Minor/Significance Unknown.

            • gentamicin

              gentamicin decreases levels of calcium chloride by inhibition of GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.

            • hydrochlorothiazide

              hydrochlorothiazide increases levels of calcium chloride by decreasing renal clearance. Minor/Significance Unknown. Risk of alkalosis, hypercalcemia.

            • hydrocortisone

              hydrocortisone decreases levels of calcium chloride by increasing elimination. Minor/Significance Unknown.

            • indapamide

              indapamide increases levels of calcium chloride by decreasing renal clearance. Minor/Significance Unknown. Risk of alkalosis, hypercalcemia.

            • iron dextran complex

              calcium chloride decreases levels of iron dextran complex by inhibition of GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.

              iron dextran complex increases levels of calcium chloride by enhancing GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.

            • iron sucrose

              calcium chloride decreases levels of iron sucrose by inhibition of GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.

              iron sucrose increases levels of calcium chloride by enhancing GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.

            • isoniazid

              isoniazid decreases levels of calcium chloride by inhibition of GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.

            • isotretinoin

              isotretinoin increases levels of calcium chloride by enhancing GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.

            • lily of the valley

              calcium chloride increases effects of lily of the valley by unspecified interaction mechanism. Minor/Significance Unknown.

            • manganese

              calcium chloride, manganese. Either decreases levels of the other by inhibition of GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown. Separate by 2 hours.

            • methyclothiazide

              methyclothiazide increases levels of calcium chloride by decreasing renal clearance. Minor/Significance Unknown. Risk of alkalosis, hypercalcemia.

            • methylprednisolone

              methylprednisolone decreases levels of calcium chloride by increasing elimination. Minor/Significance Unknown.

            • metolazone

              metolazone increases levels of calcium chloride by decreasing renal clearance. Minor/Significance Unknown. Risk of alkalosis, hypercalcemia.

            • neomycin PO

              neomycin PO decreases levels of calcium chloride by inhibition of GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.

            • paromomycin

              paromomycin decreases levels of calcium chloride by inhibition of GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.

            • polysaccharide iron

              calcium chloride decreases levels of polysaccharide iron by inhibition of GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.

              polysaccharide iron increases levels of calcium chloride by enhancing GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.

            • prednisolone

              prednisolone decreases levels of calcium chloride by increasing elimination. Minor/Significance Unknown.

            • prednisone

              prednisone decreases levels of calcium chloride by increasing elimination. Minor/Significance Unknown.

            • rose hips

              calcium chloride decreases levels of rose hips by inhibition of GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.

              rose hips increases levels of calcium chloride by enhancing GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.

            • shark cartilage

              calcium chloride, shark cartilage. pharmacodynamic synergism. Minor/Significance Unknown. May lead to hypercalcemia (theoretical).

            • sodium polystyrene sulfonate

              sodium polystyrene sulfonate increases levels of calcium chloride by decreasing renal clearance. Minor/Significance Unknown. Risk of alkalosis.

            • spironolactone

              spironolactone decreases levels of calcium chloride by increasing renal clearance. Minor/Significance Unknown.

            • streptomycin

              streptomycin decreases levels of calcium chloride by inhibition of GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.

            • teriparatide

              teriparatide increases levels of calcium chloride by pharmacodynamic synergism. Minor/Significance Unknown.

            • tobramycin

              tobramycin decreases levels of calcium chloride by inhibition of GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.

            • torsemide

              torsemide decreases levels of calcium chloride by increasing renal clearance. Minor/Significance Unknown.

            • triamcinolone acetonide injectable suspension

              triamcinolone acetonide injectable suspension decreases levels of calcium chloride by increasing elimination. Minor/Significance Unknown.

            • triamterene

              triamterene decreases levels of calcium chloride by increasing renal clearance. Minor/Significance Unknown.

            Previous
            Next:

            Adverse Effects

            Frequency Not Defined

            Erythema

            Hypomagnesemia

            Hypophosphatemia

            Hypotension

            Hypercalcemia

            Nausea

            Tissue necrosis at injection site

            Vasodilation

            Weakness

            Renal calculi

            Hot flashes

            Serum amylase increased

            Tingling sensations

            Rapid Administration

            Arrhythmia

            Bradycardia

            Calcium taste

            Sense of heat waves

            Ventricular fibrillation

            Previous
            Next:

            Warnings

            Contraindications

            VFib during CPR, hypercalcemia, risk for digitalis toxicity, hypophosphatemia, renal calculi

            IM or SC administration

            Pulseless ventricular tachycardia

            Cautions

            Use caution in hepatic impairment, sarcoidosis, CV disease, renal disease, acidosis, cor pulmonale

            Not recommended in treatment of asystole and electromechanical dissociation

            PALS no longer recommends Ca for pediatric cardiac arrest

            Life-threatening cardiac arrhythmias may occur in severe hypokalemia

            Product is irritating to veins; must not be injected into tissues, as severe necrosis and sloughing may occur; take great care to avoid extravasation or accidental injection into perivascular tissues

            Because of additive effect, administer calcium very cautiously to patients who are digitalized or who are taking effective doses of digitalis or digitalis-like preparations

            Administer injections slowly through a small needle into a large vein to minimize venous irritation and avoid undesirable reactions; it is particularly important to prevent a high concentration of calcium from reaching the heart because of the danger of cardiac syncope; if injected into the ventricular cavity in cardiac resuscitation, it must not be injected into the myocardial tissue

            Previous
            Next:

            Pregnancy & Lactation

            Pregnancy Category: C

            Lactation: As a component of human milk calcium enters milk. Use caution.

            Pregnancy Categories

            A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

            B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

            C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

            D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

            X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

            NA: Information not available.

            Previous
            Next:

            Pharmacology

            Mechanism of Action

            Bone mineral component; cofoactor in enzymatic reactions, essential for neurotransmission, muscle contraction, and many signal transduction pathways

            Pharmacokinetics

            Excretion: feces (80%) and urine (20%)

            Previous
            Next:

            Administration

            IV Incompatibilities

            Do not infuse calcium chloride in the same IV line as phosphate-containing solutions

            IV Administration

            Not for IM or SC administration

            Administration via a central or deep vein is preferred

            Visually inspect product for particulate matter and discoloration before administration

            Vial

            • 1 g (10 mL) vials of calcium chloride 10% solution contain 27 mg/mL (1.4 mEq/mL) elemental calcium Do not exceed 100 mg/minute except in emergency situations
            • If time permits, warm solution to body temp
            • For intermittent IV infusion, infuse diluted solution over 1 hr or no >45-90 mg/kg/hour (0.6-1.2 mEq/kg/hour)
            • Do not use small hand or foot veins for IV administration (severe necrosis and sloughing may occur)
            • Refer to institutional protocol
            • Stop infusion if patient experiences pain or discomfort
            • Following injection patient should remain recumbent for a short time

            Prefilled syringe

            • Prefilled 1 g (10 mL) syringe contains 27 mg or 1.4 mEq of elemental calcium per mL
            • Slow IV injection (not to exceed 1 mL/min), preferably in a central or deep vein

            Storage

            Vial: Store at 20-25ºC (68-77ºF); excursions permitted to 15-30ºC (59-86ºF)

            Syringe: Store at 20-25ºC (68-77ºF)

            Previous
            Next:

            Images

            BRAND FORM. UNIT PRICE PILL IMAGE
            calcium chloride intravenous
            -
            100 mg/mL (10 %) solution
            calcium chloride intravenous
            -
            100 mg/mL (10 %) vial
            calcium chloride intravenous
            -
            100 mg/mL (10 %) solution
            calcium chloride intravenous
            -
            100 mg/mL (10 %) solution

            Copyright © 2010 First DataBank, Inc.

            Previous
            Next:

            Patient Handout

            Patient Education
            calcium chloride intravenous

            NO MONOGRAPH AVAILABLE AT THIS TIME

            USES: Consult your pharmacist.

            HOW TO USE: Consult your pharmacist.

            SIDE EFFECTS: Consult your pharmacist.In the US -Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch.In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.

            PRECAUTIONS: Consult your pharmacist.

            DRUG INTERACTIONS: Consult your pharmacist.Keep a list of all your medications with you, and share the list with your doctor and pharmacist.

            OVERDOSE: If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call 911. Otherwise, call a poison control center right away. US residents can call their local poison control center at 1-800-222-1222. Canada residents can call a provincial poison control center.

            NOTES: No monograph available at this time.

            MISSED DOSE: Consult your pharmacist.

            STORAGE: Consult your pharmacist.Do not flush medications down the toilet or pour them into a drain unless instructed to do so. Properly discard this product when it is expired or no longer needed. Consult your pharmacist or local waste disposal company for more details about how to safely discard your product.

            Information last revised July 2016. Copyright(c) 2021 First Databank, Inc.

            IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.

            Previous
            Next:

            Formulary

            FormularyPatient Discounts

            Adding plans allows you to compare formulary status to other drugs in the same class.

            To view formulary information first create a list of plans. Your list will be saved and can be edited at any time.

            Adding plans allows you to:

            • View the formulary and any restrictions for each plan.
            • Manage and view all your plans together – even plans in different states.
            • Compare formulary status to other drugs in the same class.
            • Access your plan list on any device – mobile or desktop.

            The above information is provided for general informational and educational purposes only. Individual plans may vary and formulary information changes. Contact the applicable plan provider for the most current information.

            Tier Description
            1 This drug is available at the lowest co-pay. Most commonly, these are generic drugs.
            2 This drug is available at a middle level co-pay. Most commonly, these are "preferred" (on formulary) brand drugs.
            3 This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs.
            4 This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.
            5 This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.
            6 This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.
            NC NOT COVERED – Drugs that are not covered by the plan.
            Code Definition
            PA Prior Authorization
            Drugs that require prior authorization. This restriction requires that specific clinical criteria be met prior to the approval of the prescription.
            QL Quantity Limits
            Drugs that have quantity limits associated with each prescription. This restriction typically limits the quantity of the drug that will be covered.
            ST Step Therapy
            Drugs that have step therapy associated with each prescription. This restriction typically requires that certain criteria be met prior to approval for the prescription.
            OR Other Restrictions
            Drugs that have restrictions other than prior authorization, quantity limits, and step therapy associated with each prescription.
            Additional Offers
            Email to Patient

            From:

            To:

            The recipient will receive more details and instructions to access this offer.

            By clicking send, you acknowledge that you have permission to email the recipient with this information.

            Email Forms to Patient

            From:

            To:

            The recipient will receive more details and instructions to access this offer.

            By clicking send, you acknowledge that you have permission to email the recipient with this information.

            Previous
            Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.